All stock lists
Globe Life Inc. (New York Stock Exchange:GL)
US · Delayed Price · Currency is USD
Financial Services · Insurance - Life
157.06+2.27 (+1.47%)
Insider Score
––Not scored
GL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
GL Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.60 B | 1.60 B | 1.56 B | 1.52 B | 1.51 B | 1.48 B |
| Revenue Growth (YoY) | 5.48 % | 8.00 % | 5.35 % | 3.93 % | 3.96 % | 2.85 % |
| Cost of Revenue | 694.10 M | 2.40 B | 789.58 M | 1.06 B | 888.19 M | 1.02 B |
| Gross Profit | 901.84 M | -804.06 M | 770.03 M | 462.61 M | 624.80 M | 456.48 M |
| SG&A Expense | 422.79 M | -174.43 M | 401.90 M | 92.00 M | 0.00 | 0.00 |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 422.79 M | -174.43 M | 401.90 M | 106.35 M | 147.70 M | 143.18 M |
| Operating Income | 479.05 M | -629.62 M | 368.13 M | 356.26 M | 477.10 M | 313.30 M |
| Pretax Income | 441.23 M | 354.89 M | 334.13 M | 333.25 M | 477.10 M | 313.30 M |
| Tax Provision | 80.13 M | 67.14 M | 63.61 M | 67.25 M | 89.26 M | 60.55 M |
| Net Income | 361.11 M | 287.75 M | 270.53 M | 266.00 M | 387.84 M | 252.75 M |
| EPS (Basic) | 4.71 | 3.71 | 3.45 | 3.35 | 4.71 | 3.05 |
| EPS (Diluted) | 4.62 | 3.65 | 3.45 | 3.29 | 4.71 | 3.05 |
| Shares Outstanding | 78.22 M | 78.41 M | 78.41 M | 80.85 M | 82.02 M | 82.79 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.